More than 150,000 nontraumatic lower extremity amputations occur annually in the United States, with the majority affecting individuals with diabetes. Alarmingly, between 2009 and 2015, there was a 50 ...

Fenestrated endovascular aneurysm repair (FEVAR) has emerged as the primary treatment for complex abdominal aortic and thoracoabdominal aneurysms. Key technologic advancements—including dedicated ...

Delcath Systems, Inc. announced that it has received clearance from the FDA to initiate patient enrollment of a phase 2 clinical ...

Rampart IC, a developer of radiation shielding for interventional suites, announced the acquisition of ClearShield, ...

HistoSonics, developer of the Edison histotripsy system, announced 12-month follow-up clinical data from its prospective #HOPE4LI ...

Acute ischemic stroke (AIS) is the leading cause of adult disability in the United States and a major cause of death both domestically and worldwide. There are approximately 800,000 strokes per year ...

This is an article sponsored and authored by Inari Medical. The health care providers (HCPs) sharing their views and opinions here express their experience with Inari Medical devices. The HCPs’ ...

The prevalence of CKD is rising due to several key factors, including increasing rates of diabetes and hypertension, an aging population, improved survival rates for chronic diseases, environmental ...

An overview of current strategies for managing type II endoleaks illustrated by a case of persistent endoleak and sac enlargement after fenestrated endovascular aneurysm repair. Various embolic agents ...

A male patient in his early 60s with history of resistant HTN, hyperlipidemia, former tobacco use, coronary artery disease treated with multiple percutaneous coronary interventions, peripheral artery ...

A 61-year-old man with a history of smoking, hypertension, hyperlipidemia, type 2 diabetes mellitus, and coronary artery disease with prior percutaneous coronary intervention presented with ...